Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nectin Therapeutics Ltd

Clinical trials sponsored by Nectin Therapeutics Ltd, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New antibody drug takes on advanced cancers in first human trial Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

New antibody drug takes on advanced cancers in first human trial

Disease control Ongoing

This early-phase trial is testing a new drug called NTX-1088, which targets a protein on cancer cells, either alone or combined with the immunotherapy pembrolizumab. The study involves 90 people with advanced solid tumors that have spread or cannot be removed. The main goals are …

Phase 1 • Sponsor: Nectin Therapeutics Ltd • Aim: Disease control

Last updated Jun 27, 2026 12:26 UTC